Clorox Q3 Gross Margin Misses, Completes ERP Rollout, GOJO Deal EBITDA Neutral
Clorox’s Q3 gross margin fell short of expectations due to elevated supply chain costs and delayed savings despite completing its ERP rollout. The Cleaning business recorded solid innovation-led gains, international Glad operations strengthened distribution, and the GOJO acquisition is projected to be EBITDA neutral in year one.
1. Third-Quarter Financial Results
Clorox reported a gross margin below expectations in Q3 as higher-than-expected supply chain costs and delayed cost savings weighed on profitability. The Cleaning segment delivered strong innovation-driven growth, while the Litter business lagged and the Food category faced a mid-single-digit decline due to promotional intensity and competitive discounting.
2. Strategic Operations and Innovations
The company successfully completed its ERP implementation, aiming to enhance operational efficiency and execution across its global operations. International Glad business showed significant progress with improved distribution, and the Clorox PURE allergen platform achieved robust consumer engagement and shelf presence.
3. GOJO Acquisition and Cost Management
Clorox expects its GOJO acquisition to be EBITDA neutral in the first year, expanding its footprint in health and hygiene. Management highlighted preparedness for potential inflationary pressures in fiscal 2027, leveraging integrated margin management and a strong pipeline of cost-saving initiatives.